Tags Posts tagged with "Covid 19"

Covid 19

METRO photo

By Daniel Dunaief

Daniel Dunaief

Flying? Are we really flying? Well, sure, why not, right? Everyone else is flying.

Wait, then again, everyone else seems to be flying. What if one of those other people is sick? Don’t think too much about it and breathe through your nose. Oh, you can’t because the two masks you’re wearing are pinching your nose? Well, tough! 

They’re serving drinks and cookies? People have to lower their masks to eat and drink, right? So, doesn’t that defeat the purpose of mandatory masks? Look away from everyone who’s breathing. Yeah, that’ll help.

Okay, finally, we’re on the ground. 

Hey, this is a nice campus. The sidewalks are packed and filled with so much energy, not all of which is positive.

“Why are all these $#@! parents here this weekend? I have several tests and I don’t need them all staring at me!”

That girl is sharing her academic anxiety with her friend and anyone else within 100 feet of her. Subtle, real subtle! Tempted as I am to let her know that parents, likely including her own, make this sometimes miserable experience possible, I refrain. She might be my son’s current or future friend.

I ask two students for the location of a building. The first shrugs and points me in the wrong direction and the second nearly draws a map. Okay, one for two.

I sit just in time for the start of a talk by successful alumni, who connect their careers to the lessons they learned at school. Clever marketing! Other parents chuckle at the jokes. I imagine these parents as college students. In my mind, the presenters onstage become Broadway performers. Each of the two men and two women, which I presume is a well-planned balance of genders, does his or her rendition of “how I succeeded,” with the subtext, just feet from the school president, of, “keep paying those tuitions!”

When the session ends, the phone rings. It’s my son! He’s strolling across a lawn. Wait, is that really him? Much as I want to run over and squeeze him, I play it cool, congratulating myself on my impulse control. Well done, Dan. You haven’t embarrassed him so far, but the weekend is young yet, even if you are not. He adjusts his hair, a move I’ve seen him and almost all his friends do frequently, even while running back and forth on a basketball court. What’s with all the hair adjustment? I quietly ask for permission to hug him. Yay! He agrees. I wrap my arms around his shoulders and fight the urge to pick him up, which is probably best for my back.

As we head to his dorm, he tells me he hasn’t done laundry in nine days. I don’t know whether that’s a hint, as in, “Dad, while you’re here…” or a statement of fact.

We part company and I learn about the evolving world of the commercialization of college athletes, who can use their name, image and likeness to make money. He’s listening to a psychology lecture about, who else, Sigmund Freud.

At a football game, I wonder how it can be this cold in Louisiana. Aren’t we in the deep south? We leave before it’s over, waiting in the cool air for 11 minutes for an expensive Uber — they must know it’s parents weekend — to take two families who are heading back to the same hotel.

10 pm. Who eats this late? I’m usually half way to sleep by now. My older brother is undoubtedly already in REM sleep. My stomach is going to hate this. Shut up stomach!

Looking around the table at these families, one thing is clear: these parents adore their children.

This is part of the story of how these boys got here and, hopefully, will help them continue to learn lessons, like how to dress for a cold football game and how to make reservations in advance before a busy parents weekend so we can eat earlier.

Pixabay photo

By Leah S. Dunaief

Leah Dunaief

Talk about mixed emotions. That’s what we feel when we are driving along and suddenly see a deer running out from among the trees. They are beautiful and graceful animals, and we stop the car and point them out to our small children in the back seat, who are thrilled at the sighting, perhaps recalling Bambi. But there is a lot more to the deer story here in suburbia. 

Long Island is home to more than 20,000 white-tailed deer, and that number has been exploding because there haven’t been many threats — until now. As long as they could find enough food and survive particularly harsh winters, the occasional highway collision and the short hunting season, they were largely untroubled. 

However, they have been a nuisance to residents because they devour flowers and vegetable gardens. And while they can be the innocent carriers of an infected tick, whose bite causes the miserable Lyme disease, they are gentle enough souls who leap out of sight as humans approach.

Now it turns out that they may be a more serious problem to us. A new study in Iowa found that the deer seem to be contracting the coronavirus from humans and spreading it to one another. This means the deer could become a reservoir for deadly mutations of the virus that could then possibly be passed back to humans. In that event, another vaccine would have to be developed to target the new variant in much the same way as flu shots are modified from year to year. 

Researchers were astonished at how widespread the infection was among the deer population there, estimated at 80%. Deer hunters and others who handle deer (as road kill) are being urged to take precautions to avoid transmission, like wearing rubber gloves and a mask.

Researchers don’t know exactly how the deer get infected by humans, but they suggest it might occur when people in Iowa feed deer in their backyards, or through sewage discharges or anything partially chewed by an infected human, like a “splotch of chewing tobacco” that then might be licked by a deer. 

The study of the deer was led by veterinary microbiologists from Penn State, according to an article in The New York Times on November 9, and they were able to make their analysis by examining the lymph nodes of dead deer. But they have not yet been able to determine whether the animals were sickened by the pathogen. They also are going to examine other wild animals, especially mice, that live in close proximity to humans, to see if they too might carry the virus. 

There is well established research that shows some pathogens do move back and forth between animals and humans, including those that cause yellow fever and West Nile. And we do know our dogs and cats can get COVID-19.

Also in the news is something called epizootic hemorrhagic disease, transmitted by the EHD virus that can kill deer within 36 hours of infection. This often-fatal disease is transmitted by biting midges. We call them “no-see-ums.” Deer do not catch it from each other, nor can humans be infected by either deer or midges. But stricken deer bleed to death, especially in late summer and early fall when midges are abundant.

While there is no treatment for EHD, the first frost kills the midges, ending the outbreak. The virus was first confirmed in New York in 2007 with small outbreaks in the state’s northern counties, according to Cornell University College of Veterinary Medicine. By 2020, the affected deer were found in the lower Hudson Valley, in other states along the eastern United States, and also in zoos.

“The dead deer do not serve as a source of infection for other animals because the virus is not long lived in dead animals,” according to the Cornell Wildlife Health Lab. Suffolk County has 139 cases reported and 8 confirmed as of last week.

Colin Powell. Stock photo

“Great leaders are almost always great simplifiers, who can cut through argument, debate and doubt, to offer a solution everybody can understand.”

Those were the words of respected military and government figure, former Secretary of State Colin Powell (R), who passed away Oct. 18 as a result of COVID-19 complications amid a cancer battle. A leader who reached the peak of his military career, he grew up with humble roots. Born on April 5, 1937, in Harlem to Jamaican immigrants, Powell lived within the difficult surroundings of South Bronx. As a young man, he witnessed a great deal of crime, drugs and a lack of opportunity within this part of New York City. Later in life, Powell served as a key spokesperson for a national mentoring organization that helped children who lived within at-risk areas to reach their fullest potential.  

Graduating high school, Powell enrolled with City College of New York, where he was accepted into the Reserve Officers’ Training Corps. Right away, he was drawn to the military discipline, liked wearing a distinctive uniform and performed well within an early team setting. Powell attained the rank of cadet colonel and led the drill and ceremony team for his college’s military program. By 1958, he graduated college and began his long and distinctive career within the Army. 

Powell served with distinction on two tours of duty in Vietnam from 1962-63 and 1968-69. He saw the start of the escalation of the war in Southeast Asia, and was present for the Tet Offensive. He observed the protests that were organized against the American government’s support of the war. Wounded twice, he saved two other soldiers after a helicopter crash. 

He was highly decorated, including the Purple Heart, for his combat and leadership in South Vietnam.

This officer from the mean streets of South Bronx began his climb through a series of political jobs that were tied to the military. While he was a combat veteran, it was perceived by his superiors that he had the ability to guide the armed forces during times of peace and war. Powell was respected for his calm and confident approach which was easy to follow. He attended the U.S. Army Command and General Staff College, and gained his master’s degree at George Washington University. 

After being promoted to major, he won a White House Fellowship and was assigned to the Office of Management and Budget during the administration of President Richard Nixon (R). By 1979, Powell began his rise within senior leadership.

Powell’s education, training and experience prepared him well for senior military and government positions. This climb of promotions and responsibilities was evident when he advised former Secretary of Defense Caspar Weinberger (R). By 1987, Powell became national security adviser for President Ronald Reagan (R). 

With Powell being a combat veteran, it was no surprise that he would eventually command the armed forces during times of peace and war. He was commander of Army Forces Command during the fall of the Soviet Union and the Berlin Wall in 1989 and was now a four-star general. In October of that year, President George H. W. Bush (R) appointed Powell as the first African American officer to be chairman of the Joint Chiefs of Staff, the highest military position in the Department of Defense. 

Powell led the military during the invasion of Panama in December 1989 through January 1990 to depose its leader, Manuel Noriega. This strategically located country between North America and South America dealt drugs, and the United States feared for the stability of the Panama Canal. American soldiers quickly took over the country, deposed Noriega and demonstrated the willingness of the U.S. government to intervene within Latin American affairs. Powell also oversaw the beginning operations of the U.S. military intervention in Somalia. The hope was the U.S. could bring humanitarian aid, comfort, food and stability to this strategic but troubled East African nation that was in the midst of a civil war.

Persian Gulf War

Perhaps within his career, the strongest role that Powell oversaw was the Persian Gulf War in 1990-91. Under its president, Saddam Hussein, Iraq invaded its neighboring oil-rich nation, Kuwait, and quickly overran its forces, taking control of the small country on the Persian Gulf. Hussein had the fourth largest military in the world and there were the concerns that he would invade Saudi Arabia with its vast oil reserves. Under the direction of Bush, American soldiers were quickly sent to Saudi Arabia to protect the kingdom under the name of Operation Desert Shield. 

Usually standing next to Bush, Powell had a direct and easy approach toward identifying the military objectives of the United States and the growing coalition of foreign military forces. For several months, he worked with nations around the world, including those Arabic countries from the Middle East to thwart the tyranny of Hussein. Before the land war started, there were some 750,000 coalition forces, with the United States as the most dominant partner with 540,000 armed forces, many stationed in Saudi Arabia.  

At first, Bush hoped that air power would be enough to dislodge the Iraqi army, without committing a large amount of soldiers. The president feared excessive casualties through the strength of the Iraqi army and its known use of biological and chemical weapons. Powell understood the concerns of Bush, but he was tasked with creating a plan that would succeed in ending this conflict and restoring the previous leadership of Kuwait. Looking at the president, Powell with Gen. H. Norman Schwarzkopf at his side outlined the plans.

Powell provided Schwarzkopf with abundant resources that comprised a superior military force created within the post-Cold War world. In the background, the former Soviet leaders must have openly wondered how they would have fared within a conventional war against the United States and the major nations of the West. 

At the head of this massive force was Powell and many other senior military figures who wanted to gain a victory in order to preserve peace in this region and to also end the negative stigma over the American loss of the Vietnam War. Many of these officers were older leaders who had served in Vietnam, and were pleased to oppose the Iraqi military. 

Always a firm figure, Powell was the architect of a military force that was transported thousands of miles away and equipped for desert warfare. After several long months of waiting, the coalition was poised to move into Kuwait and Southern Iraq. 

The Allied air war destroyed the Iraqi air force, tanks, troops and Scud missile sites which targeted Saudi Arabia and Israel. That Thanksgiving, Bush, a former aviator of World War II in the Pacific, and Powell traveled to Saudi Arabia to meet Schwarzkopf.  

After the holidays, time ran out for Hussein who refused to pull out of Kuwait. Operation Desert Storm began Jan. 17, 1991, through the roots of the plans that Powell and Schwarzkopf created to defeat the well-entrenched enemy. American armor and aircraft “blitzkrieged” Iraqi positions in Kuwait and Southern Iraq. Aggressively, they cut off and destroyed any chance of the Iraqis from being resupplied, and prevented an easy retreat away from the fighting. Inside of three days, the war was over. The Iraqi forces fled, were captured and killed during this short, but intense war.  

And so Powell guided these operations that successfully obliterated the presence of Iraq in Kuwait. This local hero from meager beginnings did not attend the United States Military Academy at West Point. However, he often saw many younger officers and soldiers from the inner cities who reminded him of his own background. The immense American strength during the Persian Gulf War shocked our friends and foes toward the swift resolve of this country to carry out large-scale fighting.

Secretary of state

Retiring from the military in 1993, Powell soon joined the Republican Party, and later served as the first African American secretary of state from 2001 to 2005 for President George W. Bush (R). 

Powell made the controversial case which tried to persuade Americans that Hussein had weapons of mass destruction in Iraq after 9/11. As in the military, Powell was respected by his foreign counterparts as a secretary of state directing American foreign policy overseas. He went against the Republicans in 2008 to endorse the election of the first Black president, Barack Obama (D).

A man who positively operated in the background, Powell could be considered to be this generation’s equivalent of Jackie Robinson, Thurgood Marshall, Rosa Parks and Hank Aaron. Through his regular approach, Powell broke the color barrier through his military and political accomplishments. And within his many decades in uniform, he was one of the most trusted American military and government leaders representing the strength of this nation. Powell passed away at age 84, and is survived by his wife Alma and three children.

Rich Acritelli is a social studies teacher at Rocky Point High School and an adjunct professor of American history at Suffolk County Community College.

Rocky Point High School students Giana Imeidopf, Sean Hamilton and Zachary Gentile helped with this article.

An antiviral pill may be beneficial in treating COVID-19 in its early stage. Stock photo

When the pandemic first hit Suffolk County in March of 2020, health care providers tried what they could to treat COVID-19.

The treatment options may be on the verge of increasing, as Pfizer recently revealed the benefit of an antiviral pill they developed to treat the virus in its early stages.

The Pfizer pill, called paxlovid, “decreased hospitalization significantly,” said Dr. Bettina Fries, chief of the Division of Infectious Diseases at Stony Brook Medicine. “That’s exciting.”

The Pfizer pill, which would still need Food and Drug Administration authorization before medical care providers can administer it to patients, comes just a few weeks after Merck announced its antiviral pill molnupiravir was effective in treating people who contracted COVID-19.

Indeed, at the end of last week, Britain became the first country to approve the use of molnupiravir for people with underlying medical conditions, including heart disease and obesity.

“There is more information on molnupiravir as this drug was approved in the [United Kingdom] last Thursday,” Dr. Adrian Popp, chair of Infection Control at Huntington Hospital explained in an email. “It will be administered as soon as possible following a positive COVID-19 test and within five days of the onset of symptoms.”

As for Pfizer, it has not yet released data about its clinical trials to the scientific community, which means independent researchers haven’t reviewed the information.

Still, the introduction of new antiviral treatments advances the battle against the virus on another front.

“They are novel medications,” Popp added. “The speed by which they are being developed is amazing.”

Popp added that the pace at which the new Pfizer drug eliminates the virus and its symptoms is unclear because of limited data.

Fries said the Pfizer and Merck drugs were in different classes and worked differently, which means they may be most effective in combination.

In terms of side effects, Fries wouldn’t expect anything dramatic from either treatment.

Taking pills that reduce the severity of the disease also aren’t likely to reduce the body’s natural immunity to the virus.

“The immune system has already seen enough of the virus by the time you take the drug,” Fries said. Some of the patients in the trial probably had the virus for about a week, which is enough time for the immune system to recognize the invader and develop a natural resistance.

The timing of treatment with antiviral drugs determines its effectiveness. Drugs like Tamiflu, which prevents the worst symptoms of the flu, become less effective the longer the virus is in a patient.

“If you give this drug later, it will likely have less effect,” Fries said.

Additionally, Fries cautioned about overusing these drugs in future months and years, which can lead to viral resistance.

Fries believes the virus, like the flu, will continue to stick around and will return in waves.

The authorization of vaccines for children ages five to 11 will likely reduce the threat from the virus.

“A lot of parents will schlep their kids right away, especially before Thanksgiving,” Fries said. “Physicians and people who have a deeper understanding of vaccines feel comfortable” with them.

Fries recently received her third shot.

While the likelihood of children developing the worst symptoms of the disease is low, they contribute to the spread of the virus.

Additionally, the virus can mutate, which could make it “potentially a lot worse. There is [also] a low but potentially significant risk of long covid syndromes,” Fries said. “You don’t want your kid to have that. Children should be super duper healthy, not just a little bit healthy.”

Thanksgiving preparation

In terms of preparing for Thanksgiving, Fries urged everybody over 65 to get a booster, particularly if they received their initial vaccines at least six months ago.

Stony Brook Hospital is admitting patients who have been vaccinated and are over 65, in part because their initial vaccinations were over half a year ago.

“We see more and more older people presenting with the disease again,” Fries added. “Do it now so you have antibodies for Thanksgiving” particularly if a family has children returning from college.

Additionally, Fries urged residents and their families to get tested before coming together, which will reduce the risk of household transmission.

Even though Pfizer and Merck have produced drugs that may improve the treatment of COVID-19, Fries urged people to continue to get vaccinated.

“This kind of drug treatment does not make us say, ‘Okay, you don’t need to get vaccinated,’ Fries said. “Absolutely not.”

Fries noted that those people unwilling to receive an mRNA vaccine might get another option before too long.

The Novavax vaccine has “performed really well” in clinical trials, Fries said. “It is more of a traditional vaccine.” The Novavax facilities have had production problems. Once they resolve those issues, the company could apply for emergency use authorization.

County Executive Steve Bellone during a press conference in Hauppauge. Photo from Suffolk County

Following the recent CDC announcement, Suffolk County Executive Steve Bellone announced on Tuesday, Nov. 9 that the Suffolk County Health Department will begin administering free COVID-19 vaccines to children ages 5 to 11. 

The vaccine clinics — which will be located at the H. Lee Dennison Building in Hauppauge — will be exclusively for children ages 5 to 17.

“I am beyond pleased that the CDC has recommended that children ages 5 to 11 years old be vaccinated against COVID-19,” Bellone said. “As a father, I am encouraging all parents who may have questions to talk with their pediatrician or a trusted healthcare provider about the importance of getting their children vaccinated. This vaccine saves lives and it could save the life of your child.”

On Nov. 2, the Centers for Disease Control and Prevention gave the final clearance for the use of the Pfizer vaccine for children ages 5 to 11, following the emergency use authorization granted by the Food and Drug Administration last month. 

All children ages 5 to 11 are now eligible to receive a two-dose primary series of the pediatric formulation of the Pfizer COVID-19 vaccine, effective immediately. This is the first COVID-19 vaccine to be permitted for use in the age group, leading the way for more than 28 million children in the United States to be vaccinated as soon as possible.

To date, nearly 88 percent of county residents 18 and over have received at least one dose of the COVID-19 vaccine and 74% of all county residents have received at least one dose.

Vaccines will be administered at the H. Lee Dennison Building located at 100 Veterans Memorial Highway in Hauppauge on Tuesdays and Thursdays from 4 p.m. to 8 p.m. and on Saturdays from 9 a.m. to 2 p.m. 

 While appointments are not required, they are strongly encouraged. Walk-ins will be available on a first come, first served basis. For more information on the County’s vaccine efforts, or to schedule an appointment call 311 or visit suffolkcountyny.gov/vaccine. 

Stock photo

Local health care providers were eager to start administering doses of COVID-19 vaccines to children who are 5 to 11 years old, which they can now do after the Centers for Disease Control and Prevention approved the shots for children late Tuesday night.

“We definitely saw more cases [of COVID-19] in children after school started this year,” said Dr. Sharon Nachman, chief of the Division of Pediatric Infectious Diseases at Stony Brook Children’s Hospital. “We’d like to prevent that.”

Health care providers would also like to stop household transmission, in which a member of a home spreads the virus to everyone else with whom that person lives.

“Children usually get milder forms of COVID, but they can transmit disease to people around them,” Dr. Adrian Popp, chair of Infection Control at Huntington Hospital, explained in an email. “It is not unusual for children to bring COVID in the home and then household members to be exposed and get COVID, especially if they are unvaccinated and immunocompromised.”

In considering whether parents should get shots for their children, doctors urged parents to speak with their family pediatricians.

“They are the experts in your child’s care,” Nachman said. “They’ll have the most insight into who your kid is.”

Pfizer BioNTech said the vaccines, which were a third of the dose of an adult shot, were over 90% effective against symptomatic COVID-19.

The Food and Drug Administration issued emergency use authorization for vaccines for this age group.

“Authorization of the vaccine for younger children is an important step in keeping them healthy and providing their families with peace of mind,” Dr. Lee Savio Beers, president of the group, said in a statement. “The vaccine will make it safe for children to visit friends and family members, celebrate holiday gatherings, and to resume the normal childhood activities that they’ve missed during the pandemic.”

Doctors urged parents with children who have underlying cardiac or respiratory issues to give serious consideration to vaccinations that could prevent the spread of a virus that could be especially problematic for their children.

“Someone with underlying cardiac issues, if they were to get COVID-19, would have increased risk of poor outcomes,” Nachman said. “They should be prioritized. Waiting to get COVID is not a good idea.”

The same holds true for children with asthma, who could develop more problematic symptoms from contracting the virus, Nachman said.

While the doses for children will be lower, the immune system of younger people is more reactive than that for adults, which is why pharmaceutical companies tested a lower dose in their clinical trials.

Even with the smaller volume of the vaccine, “children will still not have waning immunity,” Nachman said. “It will be just as effective” as the higher dose for adults.

Besides having more reactive and resilient immune systems, healthy children also will likely have milder side effects from the vaccine because of the lower dosage.

To be sure, every child who is in this age range and becomes eligible for the shot shouldn’t immediately receive the vaccination.

The clinical trials didn’t include children with cancer or with other immunological difficulties.

“We did not enroll [children with those conditions] in clinical trials,” so it would be difficult to know how effective the vaccine would be for them, Nachman said.

Down the road, vaccinating a classroom of children in this age category could lead to a reduction in the current restrictions designed to protect the health of students and their educators.

“It’s too soon to say the next steps,” Nachman said, which could include learning without masks. Further information about the spread of the virus after vaccinations would inform future guidelines.

Popp added that booster needs for children in the future is also unknown.

“Data will be gathered and [officials] will see if this will become necessary,” Popp said.

From left, 8 1/2-year-old Dan Barsi, Jennifer Barsi, Maggie Barsi (age 4), James Barsi, and Lily Barsi (age 7)

By Daniel Dunaief

Daniel Dunaief

If your children are under the age of 12 and the Food and Drug Administration soon approves a COVID-19 vaccine, you’ll have many people to thank for the opportunity to return them to a more normal, and safer, childhood, including four-year-old Maggie, seven-year-old Lily and eight-and-a-half-year-old Dan Barsi.

The three siblings, who live in East Setauket with their parents James and Jennifer Barsi, recently participated in a clinical trial for the COVID-19 vaccine at Stony Brook Hospital. While the children don’t know whether they received vaccinations for the virus or the placebo, they are three of numerous children who volunteered to test the Pfizer-BioNTech vaccine to make sure it was safe before health care providers administer it to the broader population.

Their children “knew what they were signing up for,” said Dr. James Barsi, a pediatric orthopedic surgeon. “It’s something to help other people.”

Indeed, the community benefits from volunteers like the Barsis, who participate in clinical trials that evaluate the effectiveness of the treatment, help determine the correct doses, and reveal potential side effects before the rest of the population gets the COVID-19 vaccine or any other medicine or therapeutic intervention.

“We would never make advances in medicine without families — adults and children — volunteering to participate in clinical trials,” said Dr. Sharon Nachman, Chief of the Division of Pediatric Infectious Diseases at Stony Brook Children’s Hospital.

Some treatments for a range of illnesses or conditions look promising in the earlier stages of clinical development, such as phase 1 or phase 2. When they reach phase 3, during which researchers provide medicine to a much larger volunteer population, they sometimes fall short of expectations.

“Companies will tout drugs as the next best thing,” Dr. Nachman said. “When they get into phase 3, they are not better than standard therapy.”

Clinical trials on even an ineffective drug or one that produces side effects, however, can help pharmaceutical companies and health care providers by signaling what these professionals should look for in future treatments, Dr. Nachman added.

While volunteers of any age take risks by participating in these studies, they also have considerable medical oversight.

“They are well protected,” Dr. Nachman said. “When you participate in a clinical trial, you don’t just have two sets of eyes on you; you have 100 sets of eyes.”

Volunteers for clinical trials not only take some risk before everyone else in the community, but they also experience regular testing and monitoring.

The Barsi children, for example, had to have blood work and nose swabs. “We call it a brain swab,” Jennifer Barsi said. “The kids are so excited about getting a treat afterwards, but they still have to do the hard thing.”

Health care professionals throughout Long Island shared their appreciation for clinical trial volunteers. Without them “none of these innovative therapies and drugs would exist,” said Stephanie Solito, Research Manager of the Oncology Service Line at Catholic Health, which includes Smithtown-based St. Catherine of Siena and Port Jefferson-based St. Charles Hospital.

When Daniel Loen, Catholic Health’s Vice President of Oncology Services, takes any medicine, he appreciates that patients were “willing to sacrifice something or take on some kind of increased risk to get on a trial for the good of humanity and medicine.”

As for the specific COVID-19 pediatric trials, Dr. Nachman said parents and children have to approve to participate. Doctors talk with children in an age-appropriate way about these clinical trials.

Dan Barsi was born at 25 weeks old. He stayed in the hospital for several months and is now a healthy child.

Jennifer and James felt that this was their opportunity to give back to the next generation. The children who participated in clinical research before Dan was born helped make it possible for him to get the best treatment, and now they feel they’re doing the same thing.

Steve Bellone. Stock photo by Rita J. Egan

Suffolk County Executive Steve Bellone (D) tested positive for COVID-19.

The County Executive, who is vaccinated and has been observing mask mandates, is unsure of how he contracted the virus.

Bellone has mild symptoms and is currently not receiving any medical treatment.

“I hope this serves as a reminder to all residents that while we are making incredible progress in the war against COVID-19, we are not done just yet,” Bellone said in a statement. “I encourage anyone who is eligible to receive their booster shot to do so.”

At this point, no other members of his office staff or his family has tested positive.

Bellone said he feels in “good health and spirits,” according to the statement. He will continue to carry out the duties of the County Executive.

Meanwhile, the percentage of positive tests on a seven-day average in Suffolk County fell below 3% on Oct. 20, dropping to 2.9%, according to the Suffolk County Department of Health.

Local health care providers have been encouraged by the overall decline in positive tests, which they attribute in part to ongoing vaccination efforts.

The Food and Drug Administration provided emergency use authorization for the Moderna booster for a specific groups of people who were fully vaccinated at least six months ago. Those groups include: people 65 years and older; people 18 through 64 who are considered at high risk; and people 18 through 64 with occupational exposure.

The FDA also approved the use of a single booster dose for people who received the Johnson & Johnson vaccine at least two months ago.

The FDA also allowed a mix and match approach to boosters, authorizing those who received one type of vaccination to choose a different booster. Local health care providers said studies have shown that people who received the J&J vaccine had a higher antibody response after receiving a Moderna booster.

“The available data suggest waning immunity in some populations who are fully vaccinated,” Acting FDA Commissioner Janet Woodccock said in a statement. “The availability of those authorized boosters is important for continued protection against COVID-19 disease.”

Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research said the FDA would gather additional data as quickly as possible to assess the benefits and risks of the us of booster doses in additional populations and plans to update the healthcare community and the public in the coming weeks.

For more information on vaccines in the area, residents can go to the web site: suffolkcountyny.gov/vaccine.

The web site also includes answers to frequently asked questions, such as: what are the side effects after I get the COVID-19 vaccine, is it safe to get a COVID-19 vaccine if I have an underlying medical condition, and what should I do if I am exposed to COVID-19 after being vaccinated.

Early in the pandemic, Bellone remained in quarantine and managed his responsibilities from home after Deputy County Executive Peter Scully tested positive for the virus. Bellone didn’t test positive at that point, although he, like so many others in the early days of the disease, waited days for the results of his COVID test.

Suffolk County Legislators Sarah Anker and Al Krupski present a proclamation to Little Flower Children and Family Services for their service to the community. Photo from Leg. Anker's office

On Sept. 30, Suffolk County Legislator Sarah Anker and Suffolk County Legislator Al Krupski presented a proclamation to Little Flower Children and Family Services of Wading River and certificates of appreciation to each of the facility’s almost 300 staff members to thank them for working on the frontlines throughout the COVID-19 pandemic to ensure the children and families in the community were able to access much needed services. 

The legislators were joined by Corinne Hammons, President and CEO of Little Flower Children and Family Services; Erik M. Ulrich, LCSW-R, ACSW, Clinical Director, Medical and Mental Health Department; Michelle Segretto, Vice President of Residential Services; Lauren Mones, MSW, Interim Chief of Staff and Administrative Director Health Care Management and Services; Taressa Harry, Director of Communications; Steven Valentine, Maintenance Supervisor; Harold Dean, Superintendent of the Little Flower Union Free School District; and Barbara Kullen, Board of Directors Member outside at the Wading River Duck Pond for the presentation. 

“The COVID-19 pandemic has brought many challenges to our service providers, forcing them to adapt and find innovative ways to continue to service those in need,” said Leg. Anker. “Legislator Krupski and I would like to thank all the amazing staff at Little Flower that worked directly on the frontlines each day to provide our children and families with much needed support, at a time that they likely needed it the most.”

“The work that Little Flower does on a day to day, year to year basis is very important,” said Leg. Krupski. “Trying to function in the face of a global pandemic must have been very challenging. Thank you to Little Flower for their hard work, decision making and commitment to their goals. They have set a great example of courage and determination.”

“I am genuinely grateful to Legislator Anker and Legislator Krupski for taking the time to acknowledge and support Little Flower’s remarkable frontline workers and for recognizing the tough and heroic work they do every day in support of those we serve,” said President and CEO of Little Flower Children and Family Services Corinne Hammons. 

“They have demonstrated great dedication and commitment to our clients by showing up every day, leaving the safety of their homes, balancing the risk of the pandemic to provide care, comfort, and security. We are thankful and proud of our essential workers. They are the backbone of our organization and the heart of our mission, never missing a beat as they transform caring into action,” added Hammons. 

Photo from Deposit Photos

With the Food and Drug Administration expected to vote this week on boosters for Johnson & Johnson and Moderna vaccines for COVID-19, local doctors suggested the current studies may support some switching, particularly for those who received a single dose of Johnson & Johnson.

“There is preliminary data that has demonstrated that mixing and matching the vaccines may be beneficial,” said Dr. Sunil Dhuper, chief medical officer at Port Jefferson’s St. Charles Hospital.

Indeed, recent studies suggested that people who received the J&J vaccine had a considerably higher increase in their antibody response from a Moderna booster than from a second J&J shot.

“There may be some merit” to switching from the traditional method J&J deployed to create an antibody response to the mRNA-based approach from Pfizer-BioNTech and Moderna, Dhuper added.

Dr. Adrian Popp, chair of Infection Control at Huntington Hospital, added that data from studies with J&J are “showing that folks who received the initial J&J vaccine may benefit from receiving a booster with Pfizer or Moderna as this may lead to a very high immune response.”

As for side effects from the boosters, Popp explained that the reactions are similar to those for the initial series of vaccinations.

In an email, Popp noted that the Moderna booster is half the dose of the original shots, which “may lead to a decrease in side effects.”

Dr. Susan Donelan, medical director of the Healthcare Epidemiology Department at Stony Brook Medicine and assistant professor of Infectious Diseases in the Renaissance School of Medicine at Stony Brook University, is pleased that “many people are quite eager to obtain boosters. This bodes well for enhanced protection as we enter the indoor/ holiday season.”

In another encouraging sign, the percentage of people who have tested positive for COVID-19 in Suffolk County continues to decline, with the seven-day average falling to 3% as of Oct. 19, which is down from 4.2% a month earlier, according to the Suffolk County Department of Health.

Sporting events

Meanwhile, people have been attending college and professional sporting events in large numbers, often without masks. These competitions haven’t yet produced documented superspreader events.

“Outdoor venues overall provide a reduced opportunity for spread compared to indoor events,” Donelan explained in an email. “If proof of vaccination or a negative test within a set time frame (e.g. 72 hours) before the event is required for entry, it is reasonable to anticipate that inadvertent spread can be limited.”

Other health care professionals also suggested that outdoor events, despite thousands of people standing and shouting to urge on their teams, presented lower risk than indoor gatherings.

“In an outdoor event, the virus would get diluted within seconds,” said Dhuper. “You’re not going to get a high dose” of any viral particles at such a gathering.

As for the bigger picture, Popp said he is “happy to report that, as of Oct. 6, the fully vaccinated rate is 69% in Nassau and 65% in Suffolk. It is not as high as we would like to see, but it is an increase of 7% to 8% since July 29.”

Health care professionals urged residents who haven’t already done so to get a flu shot soon.

“With all the attention on COVID vaccinations, masks will come off as people are reassured that they are safer in regards to COVID, and flu will ‘take advantage’ of this scenario,” Donelan explained. “We need to be vaccinated against both viruses.”